205 related articles for article (PubMed ID: 26743236)
1. Synthetic Bax-Anti Bcl2 combination module actuated by super artificial hTERT promoter selectively inhibits malignant phenotypes of bladder cancer.
Liu L; Liu Y; Zhang T; Wu H; Lin M; Wang C; Zhan Y; Zhou Q; Qiao B; Sun X; Zhang Q; Guo X; Zhao G; Zhang W; Huang W
J Exp Clin Cancer Res; 2016 Jan; 35():3. PubMed ID: 26743236
[TBL] [Abstract][Full Text] [Related]
2. Synthetic miRNA sponges driven by mutant hTERT promoter selectively inhibit the progression of bladder cancer.
Zhuang CL; Fu X; Liu L; Liu YC; Huang WR; Cai ZM
Tumour Biol; 2015 Jul; 36(7):5157-63. PubMed ID: 25775949
[TBL] [Abstract][Full Text] [Related]
3. Expression of a recombinant vector of a mutant human telomerase reverse transcriptase gene in human bladder cancer cell line T24, and its clinical significance.
Fu WJ; Hong BF; Huang JJ; Xu B; Gao JP; Wang XX; Huang CF
BJU Int; 2005 Oct; 96(6):890-4. PubMed ID: 16153224
[TBL] [Abstract][Full Text] [Related]
4. Synthetic Tet-inducible small hairpin RNAs targeting hTERT or Bcl-2 inhibit malignant phenotypes of bladder cancer T24 and 5637 cells.
Lin J; Liu Y; Zhan Y; Zhuang C; Liu L; Fu X; Xu W; Li J; Chen M; Cai Z; Huang W
Tumour Biol; 2016 Mar; 37(3):3115-21. PubMed ID: 26427661
[TBL] [Abstract][Full Text] [Related]
5. Low-dose etoposide enhances telomerase-dependent adenovirus-mediated cytosine deaminase gene therapy through augmentation of adenoviral infection and transgene expression in a syngeneic bladder tumor model.
Shieh GS; Shiau AL; Yo YT; Lin PR; Chang CC; Tzai TS; Wu CL
Cancer Res; 2006 Oct; 66(20):9957-66. PubMed ID: 17047058
[TBL] [Abstract][Full Text] [Related]
6. Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers.
Gu J; Kagawa S; Takakura M; Kyo S; Inoue M; Roth JA; Fang B
Cancer Res; 2000 Oct; 60(19):5359-64. PubMed ID: 11034071
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis.
Luo HB; Li B; Yuan WG; Xu CR
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):730-735. PubMed ID: 26489630
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Bcl-2 expression by a novel tumor-specific RNA interference system increases chemosensitivity to 5-fluorouracil in Hela cells.
Huang SL; Wu Y; Yu H; Zhang P; Zhang XQ; Ying L; Zhao HF
Acta Pharmacol Sin; 2006 Feb; 27(2):242-8. PubMed ID: 16412276
[TBL] [Abstract][Full Text] [Related]
9. hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity.
Gu J; Andreeff M; Roth JA; Fang B
Gene Ther; 2002 Jan; 9(1):30-7. PubMed ID: 11850720
[TBL] [Abstract][Full Text] [Related]
10. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
[TBL] [Abstract][Full Text] [Related]
11. Effects of combined siRNA-TR and -TERT on telomerase activity and growth of bladder transitional cell cancer BIU-87 cells.
Cheng W; Wei Z; Gao J; Zhang Z; Ge J; Jing K; Xu F; Xie P
J Huazhong Univ Sci Technolog Med Sci; 2010 Jun; 30(3):391-6. PubMed ID: 20556588
[TBL] [Abstract][Full Text] [Related]
12. [A study on selective killing effect of Hsv-tk/GCV driven by human telomerase catalytic subunit promoter on human lung cancer cell A549].
Tang XJ; Wang YP; Zhou QH; Che GW; Chen XH; Zhu DX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Apr; 24(2):148-52. PubMed ID: 17407070
[TBL] [Abstract][Full Text] [Related]
13. An enhanced hTERT promoter-driven CRISPR/Cas9 system selectively inhibits the progression of bladder cancer cells.
Huang X; Zhuang C; Zhuang C; Xiong T; Li Y; Gui Y
Mol Biosyst; 2017 Aug; 13(9):1713-1721. PubMed ID: 28702647
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of telomerase with human telomerase reverse transcriptase antisense enhances tumor necrosis factor-alpha-induced apoptosis in bladder cancer cells.
Gao XD; Chen YR
Chin Med J (Engl); 2007 May; 120(9):755-60. PubMed ID: 17531113
[TBL] [Abstract][Full Text] [Related]
15. [In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter].
Kong BH; Song Y; Ma DX; Qu X; Jiang S
Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):390-5. PubMed ID: 15312323
[TBL] [Abstract][Full Text] [Related]
16. [An experimental study on targeting suicide gene therapy for lung cancer with HSV-TK driven by hTERT promoter].
Wang YP; Tang XJ; Zhou QH; Che GW; Chen XH; Zhu DX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):701-5. PubMed ID: 19024294
[TBL] [Abstract][Full Text] [Related]
17. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract][Full Text] [Related]
18. shRNA-targeted hTERT suppress cell proliferation of bladder cancer by inhibiting telomerase activity.
Zou L; Zhang P; Luo C; Tu Z
Cancer Chemother Pharmacol; 2006 Feb; 57(3):328-34. PubMed ID: 16028098
[TBL] [Abstract][Full Text] [Related]
19. Bortezomib-mediated down-regulation of telomerase and disruption of telomere homeostasis contributes to apoptosis of malignant cells.
Ci X; Li B; Ma X; Kong F; Zheng C; Björkholm M; Jia J; Xu D
Oncotarget; 2015 Nov; 6(35):38079-92. PubMed ID: 26472030
[TBL] [Abstract][Full Text] [Related]
20. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
Chen R; Zhu J; Dong Y; He C; Hu X
Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
